期刊文献+

血清钾、肌酶及甲状腺激素水平变化对甲亢并周期性麻痹患者预后的影响 被引量:4

Study on effect of serum potassium,muscle enzymes and thyroid hormone levels in patients with hyperthyroidism and periodic paralysis
原文传递
导出
摘要 目的:探讨血清钾、肌酶及甲状腺激素水平变化对甲亢并周期性麻痹(简称甲亢周麻,TPP)患者病情和预后的影响。方法:采用回顾性分析方法选取我院TPP患者50例,用全自动生化分析仪检测血清钾、肌酶及甲状腺激素水平浓度。结果:所有TPP患者与正常参考值比较均有血清钾下降,游离三碘甲状腺原氨酸(FT3)、游离甲状腺素(FT4)、总三碘甲状腺原氨酸(T3)、总甲状腺素(T4)水平上升,促甲状腺素(TSH)水平下降;其中39例患者肌酸激酶(CK)水平上升;28例患者肌酸激酶同工酶(CK-MB)水平上升;31例患者天门冬氨酸转氨酶(AST)水平上升。血清钾分别与CK、CK-MB、AST各指标之间呈负相关。结论:低钾性周期性麻痹(HOPP)为其临床特点,及时控制甲亢并维持血钾正常是治疗关键,早期诊断及时补钾治疗与预后密切相关,合并甲亢者治疗甲亢同时补钾并加强护理,有助于病情判断,提高治疗效果。 Objective: To study the effect of serum potassium,muscle enzymes and thyroid hormone levels in patients with hyperthyroidism and periodic paralysis.Methods: Retrospective analysis was used to analyze 50 TPP patients in the hospital. Serum potassium,muscle enzymes and thyroid hormone levels were detected with automatic biochemical analyzer.Results: Comparing with reference values,all TPP patients′ serum potassium and TSH decreased,FT3,FT4,T3 and T4 increased.And 39 patients had CK increase.28 patients had CK-MB increase.31 patients had AST increase.Serum potassium was negatively correlated to CK,CK-MB and AST respectively.Conclusion: HOPP was one of the clinical features of HPP.Timely control of hyperthyroidism and maintenance of normal serum potassium was the key to treatment. Early diagnosis and timely potassium supplement were closely related to the prognosis,which contributed to judge disease and improve curative effect.
出处 《中国卫生检验杂志》 北大核心 2012年第3期536-537,542,共3页 Chinese Journal of Health Laboratory Technology
关键词 血清钾 肌酶 甲状腺激素 甲亢并周期性麻痹 预后 Serum Potassium Muscle Enzymes Hyperthyroidism and Periodic Paralysis Prognosis
  • 相关文献

参考文献6

二级参考文献25

  • 1王刚,祝延,孔德虎,陈生弟.离子通道病研究的现状和展望[J].生理科学进展,2004,35(3):251-254. 被引量:12
  • 2沈定国.周期性麻痹诊断治疗中的几个问题[J].中华神经科杂志,2004,37(3):193-195. 被引量:48
  • 3Ptacek LJ, Tawil R, Griggs RC, et al. Dilhydropyridine receptor mutations cause hypokalemic periodic paralysis[J]. Cell, 1994, 77(6):863 -868.
  • 4Cannon SC. An expanding view for the molecular basis of familial periodic paralysis[J]. Neuromuscul Disord, 2002, 12(6): 533-543.
  • 5Monnier N, Procaccio V, Stieglitz P, et al. Malignant-hyperthermia susceptibility is associated with a mutation of the alpha 1-subunit of the human dihydropyridine-sensitive L-type voltage-dependend calcium-channel receptor in skeletal muscle(see comments)[J]. Am J Hum Genet, 1997, 60(6): 1316-1325.
  • 6Plassart E, Elbaz A, Santos JV, et al. Genetic heterogeneity in hypokalemic periodic paralysis [J]. Hum Genet, 1994, 94 (5):551-556.
  • 7Bulman DE, Scoggan KA, van Oene MD, et al. A novel sodium channel mutation in a family with hypokalemic periodic paralysis[J].Neurology, 1999, 53(9): 1932-1936.
  • 8Struyk AF, Scoggan KA, Bulman DE, et al. The human skeletal muscle Na^+ channel mutation R669H associated with hypokalemic periodic paralysis enhanced slow inactivation[J]. J Neurosci, 2000,20(23): 8610-8617.
  • 9Jurkat-Rott K, Mitrovic N, Hang C, et al. Voltage-sensor sodium channel mutation cause hypokalemic periodic paralysis type 2 enhanced inactivation and reduced current [J]. Proc Natl Acad Sci,2000, 97(17): 9549-9554.
  • 10Sugiura Y, Makita N, Li L, et al. Cold induces shifts of voltage dependence in mutant SCN4A, causing hypokalemic periodic paralysis[J]. Neurology, 2003, 61 (7): 914-918.

共引文献21

同被引文献34

  • 1胡建霞,阎胜利.钙通道α1亚基基因11外显子1551位点T/C多态性与甲亢性周期性麻痹的相关性研究[J].中华内分泌代谢杂志,2006,22(6):576-577. 被引量:4
  • 2陈文彬.诊断学[M].7版.北京:人民卫生出版社,2010:267.
  • 3Wendorf M, Goldfine ID. Archaeology of NIDDM. Excavation of the "thrifty" genotype[ J]. Diabetes,1991,40(2) :161-165.
  • 4Kung AW, Lau KS, Fong GC, et al. Association of novel single nucleo- tide polymorphisms in the calcium channel alpha 1 subunit gene ( Ca (v) 1. 1 ) and thyrotoxic periodic paralysis [ J ]. J Clin Endocrinol Metab, 2004,89 ( 3 ) : 1340-1345.
  • 5Lane AH, Markarian K, Braziunene I. Thyrotoxic periodic paralysis as- sociated with a mutation in the sodium channel gene SCN4A[ J]. Jour- nal of pediatric endocrinology & metabolism, 2004, 17 ( 12 ) : 1679- 1682.
  • 6Wang W, Jiang L, Ye L, et al. Mutation screening in Chinese hypokale- mic periodic paralysis patients[ J ]. Mol Genet Metab JT-Molecular ge- netics and metabolism ,2006,87 (4) :359-363.
  • 7Kung AW, Lau KS, Cheung WM,et al. Thyrotoxic periodic paralysis and polymorphisms of sodium-potassium ATPase genes [ J ]. Clin En- docrinol (Oxf) JT-Clinical endocrinology,2006,64 (2) : 158-161.
  • 8Kim TY, Song JY, Kim WB, et al. Argl 6Gly polymorphism in beta2- adrenergic receptor gene is not associated with thyrotoxic periodic pa- ralysis in Korean male patients with Graves' disease [ J ]. Clin Endo- crinol (Oxf) JT-Clinical endocrinology,2005,62 (5) : 585 -589.
  • 9Lu KC, Hsu YJ, Chiu JS, et al. Effects of potassium supplementation on the recovery of thyrotoxic periodic paralysis [ J ]. Am J Emerg Med, 2004,22 ( 7 ) : 544-547.
  • 10贺宜伟,涂湘炎.甲状腺功能亢进症并低钾性周期性麻痹[J].哈尔滨医药,2011,32(1):1.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部